An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre.
about
Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patientsCarbapenem-Resistant Non-Glucose-Fermenting Gram-Negative Bacilli: the Missing Piece to the PuzzleCumulative and acute toxicity of repeated high-dose tobramycin treatment in cystic fibrosisLung infections associated with cystic fibrosis.Persistence of a multidrug-resistant Pseudomonas aeruginosa clone in an intensive care burn unit.Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis cloneEpidemic spread of Pandoraea apista, a new pathogen causing severe lung disease in cystic fibrosis patients.Molecular epidemiology of chronic Pseudomonas aeruginosa airway infections in cystic fibrosis.Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients.Infection control in cystic fibrosis.Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosisPhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patientsAntibiotic treatment of multidrug-resistant organisms in cystic fibrosis.PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patientsMolecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patientsPhenotypic and Genotypic Comparison of Epidemic and Non-Epidemic Strains of Pseudomonas aeruginosa from Individuals with Cystic Fibrosis.Transient in vivo selection of a constitutively cephalosporin resistant Enterobacter cloacae causing ventriculitis.Isolation of infectious cystic fibrosis patients: results of a systematic review.Quantitative analysis of the IgG and IgG subclass immune responses to chromosomal Pseudomonas aeruginosa beta-lactamase in serum from patients with cystic fibrosis by western blotting and laser scanning densitometry.Comparison of ribotyping and genome fingerprinting of Pseudomonas aeruginosa isolates from cystic fibrosis patientsMicrobiology of airway disease in patients with cystic fibrosis.Multidrug-resistant organisms in cystic fibrosis: management and infection-control issues.Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airwayUse of a pilin gene probe to study molecular epidemiology of Pseudomonas aeruginosa.Conversion of Pseudomonas aeruginosa to the phenotype characteristic of strains from patients with cystic fibrosis.Reactive oxygen species drive evolution of pro-biofilm variants in pathogens by modulating cyclic-di-GMP levels.Twenty-five-year outbreak of Pseudomonas aeruginosa infecting individuals with cystic fibrosis: identification of the prairie epidemic strain.Defining routes of airborne transmission of Pseudomonas aeruginosa in people with cystic fibrosis.The problems of antibiotic resistance in cystic fibrosis and solutions.Biofilm formation mechanisms and targets for developing antibiofilm agents.Evaluation of random amplified polymorphic DNA typing of Pseudomonas aeruginosa.Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis.Pseudomonas aeruginosa and Burkholderia cepacia infection in cystic fibrosis patients treated in Toronto and Copenhagen.Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa.Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients.Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains.Heterogeneity, persistence, and distribution of Pseudomonas aeruginosa genotypes in cystic fibrosis patients.Dynamics and spatial distribution of beta-lactamase expression in Pseudomonas aeruginosa biofilmsElective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs.Infection prevention and control guideline for cystic fibrosis: 2013 update.
P2860
Q24658094-C7F0F9CC-ECDA-4EB2-A56D-2F2E6DB3EA3FQ28078925-CBE23CF8-85A9-485B-B47C-EC5869059CF2Q28361867-DF83EACA-A761-41FE-87F5-495039DE9CACQ30080000-27EEB73E-B399-4200-9705-F9F9AE17B05DQ33666495-9FF47898-6951-43BB-80E4-503A8F7B067FQ33911762-1ECE254F-21F1-43C4-9341-FC7C1DCADDBDQ34266590-687AC469-D6C1-436E-ABA7-1C52D2CF4DC9Q34500683-FF110C91-28DA-403E-8AC5-1511C636E8B6Q34565049-197425AA-6009-4FAB-B17B-4721DDC1F4F3Q35545544-21792EC9-32CF-4C6D-9683-530B274DCEA9Q35563227-71A18D6B-D650-4AE7-8ACA-FABB0283EACDQ35598578-DD2A96F3-F8F5-4F12-961B-6B2AF6D62EE5Q35627661-37C70D75-41F1-4210-9136-9A30D0953078Q35689189-D1AA4FC2-9440-4399-AC2E-0D4A2D8400A0Q35784162-B4CD2825-C574-486A-97B2-C37F9A7ADB0FQ35849694-994F16C3-1215-48E1-9C2B-28C7A46606B9Q35892907-080A6600-B0BE-4807-B106-D34C0285BB1BQ36112367-7FBA7088-8147-45AB-BFC2-C4E1AFDE1A4EQ36496456-5D8122AD-E72D-486A-8C14-4E5BA39F6F65Q36527531-672374A7-B7DB-47FE-9006-4A6E2C70DCC6Q36636914-22E67807-41A2-40F8-957F-1C6BBD966742Q36670892-2E4E6FA4-C318-4211-B78A-313E45ADAA56Q36889877-2B22D495-AC67-4DE1-8A02-73525CB978EFQ37162920-7EAEB50B-4BFA-48D8-BA96-1D0C9BE45AFFQ37225824-D15F34B2-3D72-4809-AF8A-3AB51B094F1EQ37464130-866DBD78-4398-414C-B0E5-CD5E0F2CB760Q37713415-AC5D4333-BD98-4D69-8C41-8E870745E4F7Q37775628-A41624F1-46EC-43C2-ACFD-4540A8E56E77Q38300820-67E3BD2A-121A-40FC-8F0A-0344F4941175Q38421808-92FFD6C6-08BE-4BBB-9D1D-A983865A7BECQ39462625-664B7A20-317B-481B-8B65-3545F7212F0BQ39474739-BBAB2F0E-6827-46D4-BCFA-A7AE28415AEDQ39474744-56D86EDC-5F4A-4338-9002-87FD9B679A47Q39866892-6337FCFC-C7E1-4DAB-BA6F-66A80FCFEE5CQ40188725-9BA42FC3-53A0-4B6D-BACF-FC2BE4E4BB91Q40196040-2C84131F-560C-4FC6-9268-1EEF0FED87D2Q40213743-4AB327F0-FC7E-4E5E-9F44-A6DD67814C84Q40705879-488EA64F-1229-44DA-8F8F-4E40FEF9F6D0Q42200170-3A21CB62-0053-4557-87CA-E21B4348D697Q42206103-C28C2307-E983-443F-B01C-6FB24F3FAEAE
P2860
An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre.
@en
An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre.
@nl
type
label
An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre.
@en
An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre.
@nl
prefLabel
An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre.
@en
An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre.
@nl
P2093
P921
P356
P1476
An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre.
@en
P2093
P304
P356
10.1093/JAC/17.4.505
P407
P577
1986-04-01T00:00:00Z